The DNA cords of the Serious Acute Respiratory Syndrome (SARS) virus were utilized to invent the brand-new SARS DNA Vaccine.
The National Institute of Allergy and Infectious Diseases (NIAID) disclosed in its newest thesis, which was published in the current edition of Nature, one of the renowned science magazines of the world, that as a result of the insertion of the SARS DNA Vaccine inside a mouse, it was confirmed to be effective in immunotherapy.
DNA Vaccine is comprised of a portion of the DNA of a virus, which is called a plasmid, in contrast to the existing vaccine which directly mitigates or kills the virus to produce its ingredient.
When this vaccine is injected into a patients body, a similar sort of protein, which resembles that on the surface of SARS virus, is formed and plants the immunity component against the SARS viruses into the body.
NIAID explained that its two different methods of experiment were proved to be effective on a mouse. After injecting the DNA vaccine into a mouse and allowing it to be exposed to the SARS virus, the mouse was confirmed to be either totally free of the viruses or only contained a small amount of viruses, which is under one-millionth compared to an unvaccinated mouse.
NIAID has disclosed that clinical diagnosis, which targets this vaccine, can be started from the end of this year.